Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.

Liquid biopsy and minimal residual disease - latest advances and implications for cure

Pantel, Klaus, Alix-Panabières, Catherine · 2019 · Nature Reviews Clinical Oncology

Abstract

Liquid biopsy has been introduced as a new diagnostic concept predicated on the analysis of circulating tumour cells (CTCs) or circulating tumour-derived factors, in particular, cell-free tumour DNA (ctDNA). Highly sensitive liquid biopsy assays have been developed that can now be applied to detect and characterize minimal residual disease (MRD), which reflects the presence of tumour cells disseminated from the primary lesion to distant organs in patients who lack any clinical or radiological signs of metastasis or residual tumour cells left behind after local therapy that eventually lead to local recurrence. This application is the new frontier of liquid biopsy analyses, which are challenged by the very low concentrations of CTCs and ctDNA in blood samples. In this Review, we discuss the key technologies that can be used to detect and characterize CTCs in surveillance of MRD and provide a brief overview of similar roles of ctDNA analyses. We then focus on the current clinical data on the use of CTCs and ctDNA in the detection and monitoring of MRD and in obtaining information on therapeutic targets and resistance mechanisms relevant to the management of individual patients with cancer.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41571-019-0187-3

Cites

157 of 157 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 157 references

Cited by

See all 1,110

Metadata

Authors
Pantel, K., & Alix-Panabières, C.
Affiliations
University Medical Center Hamburg-Eppendorf (DE)
Corresponding author
Pantel, Klaus
Venue
Nature Reviews Clinical Oncology
Published
2019-02-22
Volume
16
Issue
7
Pages
409-424
ISSN
  • 1759-4774 (ISSN-L)
  • 1759-4782
OpenAlex
W2917102036
Cited by
1,110
References
157
Citations by year
2026: 125 · 2025: 132 · 2024: 144 · 2023: 167 · 2022: 165 · 2021: 183 · 2020: 126 · 2019: 67
FWCI
12.96
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature Reviews Clinical Oncology (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
Keywords
liquid biopsy, minimal residual disease, circulating tumor cells, MRD monitoring, cancer surveillance, therapeutic target, drug resistance mechanisms, cancer management
MeSH terms
Cell-Free Nucleic Acids, Liquid Biopsy, Humans, Neoplastic Cells, Circulating, Prognosis, Neoplasm, Residual, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Liquid biopsy and minimal residual disease - latest advances and implications for cure. https://app.cochat.ai/papers/10.1038/s41571-019-0187-3
The paper
Pantel, K., & Alix-Panabières, C. (2019). Liquid biopsy and minimal residual disease - latest advances and implications for cure. Nature Reviews Clinical Oncology. https://doi.org/10.1038/s41571-019-0187-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.